Abstract
Overactive bladder (OAB), defined as a symptom complex consisting of urgency, with or without urge incontinence, in the absence of urinary tract infection or other obvious pathology, is a diagnosis affecting millions of Americans and patients around the world and is associated with significant secondary morbidity and mortality. The economic burden and prevalence of OAB is increasing in the United States, and its underlying etiology can be attributed to multiple factors. In addition to aging, pelvic floor weakness and bladder outlet obstruction, a number of medical conditions can lead to the symptoms of overactive bladder. Recognition and proper management of associated medical conditions can lead to improved patient outcomes and decreased expenditure of healthcare resources.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
• Haylen BT, de Ridder D, Freeman RM, et al.: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;5–26. A understanding of the definition of overactive bladder is important when reviewing relevant literature.
Abrams P, Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function: report from the standardization subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.
Abrams P, Blaivas JG, Stanton S, et al. The standardization of terminology of lower urinary tract function. Neurourol Urodyn. 1988;7:403–26.
Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14.
• Tikkinen KA. Epidemiology of Nocturia - Results from the FINNO Study. Tampere University Press. 2010. Prevalence of OAB must be considered in the context of any underlying pathology.
Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology. 2010;75(3):526–32.
• Robinson D, Cardozo L. Overactive bladder: diagnosis and management. Maturitas. 2012;71(2):188–93. Article discusses the difference between overactive bladder and detrusor overactivity.
Hashim H, Abrams P: Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006.191–195.
Brown JS. Diabetic Cystopathy—What Does it Mean? J Urol. 2009;181(1):13–4.
Lee WC, Wu HP, Tai TY, et al. Effects of Diabetes on Female Voiding Behavior. J Urol. 2004;172(3):989–92.
Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn. 2007;26(6):807–13.
Liu RT, Chung MS, Lee WC, et al. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology. 2011;78(5):1040–5.
Chiu AF, Huang MH, Wang CC, Kuo HC. Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus. Int J Urol. 2012. 10.1111/j.1442-2042.2012.03095.x.
Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270–6.
Rosenbaum JF, Pollack MH. Treatment-emergent incontinence with lithium. J Clin Psych. 1985;46(10):444–5.
Fry CH, et al.: Incontinence. Abrams P, Cardozo L, Khoury S, Wein A, editors. Health Publications. 2005;313–362.
de Groat WC, Booth AM. Nervous Control of the Urogenital System (Autonomic Nervous System). Harwood Academic. 1993;291–347.
Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84(3):935–86.
Janig W, Morrison JF. Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res. 1986;87–114.
Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–66.
Tubaro A, Puccini F, De Nunzio C, et al. The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review. Curr Urol Rep. 2012;13(5):335–42.
Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psych. 1993;245–250
• Wolfe DL, Legassic M, McIntyre A, et al.: Bladder Health and Function Following Spinal Cord Injury. Spinal Cord Inj Rehabil Evid. 2012;1–143. It is important to consider the urologic symptoms expected based on the level of spinal cord lesion.
Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neural Neurosurg Psychiatry. 1993;245–250
Onal B, Siva A, Buldu I, et al. Voiding Dysfunction due to Multiple Sclerosis: a Large Scale Retrospective Analysis. Int Braz J Urol. 2009;35(3):326–33.
Kasabian NG, Krause I, Brown WE, et al. Fate of the upper urinary tract in multiple sclerosis. Neurourol Urodyn. 1995;14(1):81–5.
Hall SA, Curto TM, Onyenwenyi A, et al.: Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey. Neurourol Urodyn. 2012;1149–55.
Winge K, Nielsen KK. Bladder dysfunction in advanced parkinson's disease. Neurourol Urodyn. 2012;31(8):1279–83.
Iacovelli E, Gilio F, Meco G, et al. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease. Mov Disord. 2010;25(9):1203–9.
Ragab MM, Mohammed ES. Idiopathic Parkinson's disease patients at the urologic clinic. Neurourol Urodyn. 2011;30(7):1258–61.
Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord. 2002;17(5):867–76.
Ahmed HU, Shergill IS, Arya M, Shah PJ. Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol. 2006;3(7):368–80.
Mahfouz W, Corcos J. Management of detrusor external sphincter dyssynergia in neurogenic bladder. Eur J Phys Rehabil Med. 2011;47(4):639–50.
Cruz CD, Cruz F. Spinal cord injury and bladder dysfunction: new ideas about an old problem. Sci World J. 2011;11:214–34.
Erol B, Koçak T, Kadioğlu A, et al. The relationship between level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Ulus Travma Acil Cerrahi Derg. 2009;15(4):377–82.
Podnar S, Trsinar B, Vodusek DB. Bladder dysfunction in patients with cauda equina lesions. Neurourol Urodyn. 2006;25(1):23–31.
Mehdizadeh M, Roohi A, Hemami M, Esfahani ST. Is There Any Association between Spina Bifida Occulta and Primary Vesicoureteral Reflux? Iranian J Ped. 2010;20(3):348–52.
de Jong TP, Chrzan R, Klijn AJ, Dik P. Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008;23(6):889–96.
Sakakibara R, Hattori T, Uchiyama T, et al. Uroneurological assessment of spina bifida cystica and occulta. Neurourol Urodyn. 2003;22(4):328–34.
Chandra MS. Can urodynamic studies be dispensed with in the initial urologic management of children with meningomyelocele? A study of 30 cases and review of the literature. J Ped Urol. 2007;3(3):195–9.
Nitti VW, Adler H, Combs AJ. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996;155(1):263–6.
Nakayama H, Jørgensen HS, Pedersen PM, et al. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28(1):58–62.
Gupta A, Taly AB, Srivastava A, Thyloth M. Urodynamics post stroke in patients with urinary incontinence: Is there correlation between bladder type and site of lesion? Ann Indian Acad Neurol. 2009;12(2):104–7.
Kiefer M, Unterberg A. The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int. 2012;109(1–2):15–25.
Sakakibara R, Uchiyama T, Kanda T, et al. Urinary dysfunction in idiopathic normal pressure hydrocephalus. Brain Nerve. 2008;60(3):233–9.
• Sakakibara R, Uchida Y, Ishii K, et al. Correlation of right frontal hypoperfusion and urinary dysfunction in iNPH: a SPECT study. Neurourol Urodyn. 2012;31(1):50–5. Important study showing that in patients with NPH, urinary dysfunction correlates with right frontal lobe hypoperfusion. This study may help uncover the higher cortical centers involved in micturition.
Greenberg BM. Treatment of acute transverse myelitis and its early complications. Continuum (Minneap Minn). 2011;17(4):733–43.
Pizzorno R, Simonato A, Esposito M, et al. Vesical sequelae of transverse myelitis. Long-term urodynamics observations in adult patients. Urologia. 2009;76(2):101–3.
Nakipoglu GF, Ozgirgin N. Urodynamic evaluation and rehabilitation outcomes in transverse myelitis. Neurosciences (Riyadh). 2009;14(1):37–40.
Tanaka ST, Stone AR, Kurzrock EA. Transverse myelitis in children: long-term urological outcomes. J Urol. 2006;175(5):1865–8.
Sakakibara R, Uchiyama T, Kuwabara S, et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barré Syndrome. Neurourol Urodyn. 2009;28(5):432–7.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, M.B., Weiss, J.P. Medical Causes of Overactive Bladder. Curr Bladder Dysfunct Rep 8, 51–56 (2013). https://doi.org/10.1007/s11884-012-0168-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-012-0168-1